What is Jeuveau? 

Jeuveau, also known as “Newtox”, is the first FDA-approved neurotoxin in the US that is approved for aesthetics only. Jeuveau is approved for “temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adults.” With this launch, Evolus has successfully produced the first new neurotoxin to hit the market in years.

jeuveau, xeomin, newtox, botox, neurotoxin, fda approved

Dr. Kay is proud to offer Newtox in her office as of Spring of 2019, in addition to the classic options of Botox, Xeomin and Dysport. Come see Dr. Kay to try the newest neurotoxin on the market!

“Evolus is the first company in nearly a decade to enter the fast-growing U.S. aesthetic neurotoxin market. What makes Evolus unique is our focus on delivering performance beauty products with a customer-centric approach. We are pleased to introduce Jeuveau™, the first FDA approved neurotoxin dedicated to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure™ technology.” – David Moatazedi, President and Chief Executive Officer of Evolus

Source: Evolus’s Jeuveau press release.